Bydureon

Short answer If you can’t get Ozempic (semaglutide), common medication alternatives are other GLP‑1 receptor agonists (tirzepatide, liraglutide, dulaglutide, exenatide, oral semaglutide) or, depending on your goal (blood‑sugar control vs. weight loss), other diabetes drugs (metformin, SGLT2 inhibitors) or non‑drug options (lifestyle change, bariatric care). Which is “best” depends on your diagnosis, goals, insurance and medical history — talk with a clinician first. What the main drug alternatives are (brand names and why someone would pick them) Tirzepatide — Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management): often produces greater weight loss and A1c reduction than many GLP‑1s in trials. Good option if Ozempic is unavailable and you qualify medically. Liraglutide — Victoza (diabetes) / Saxenda (weight management): long track record for both glucose control and weight loss; useful if you prefer a drug other than semaglutide. Dulaglutide — Trulicity: once‑weekly injection for type 2 diabetes with good A1c lowering and convenient dosing. Exenatide — Byetta (twice‑daily) / Bydureon (weekly): older GLP‑1 choices; may be an option if others aren’t available. Oral semaglutide — Rybelsus: an oral form of semaglutide if injectables are the problem (absorption and dosing differ; requires daily dosing and fasting rules). Other classes (if the goal is diabetes control rather than weight loss): metformin, SGLT2 inhibitors (Jardiance, Farxiga), DPP‑4 inhibitors — these don’t typically produce the weight loss GLP‑1s do but address blood glucose and cardiovascular/renal outcomes in certain patients. Non‑pharmacologic/other: prescription devices (Plenity), behavior programs, and bariatric surgery for qualifying patients. Important safety notes GLP‑1s and tirzepatide have contraindications and side effects (nausea, pancreatitis risk, possible thyroid C‑cell tumor risk in animals). They need medical screening (history of medullary thyroid carcinoma or MEN2, pancreatitis, pregnancy plans, etc.) and follow‑up. A clinician must evaluate labs, interactions, and suitability before prescribing. Who prescribes these medicines online (examples and why) These are telehealth options that commonly evaluate and can prescribe GLP‑1s or other diabetes/weight meds depending on state regulations, clinical appropriateness and availability. Availability and formularies change, so confirm with each service. Primary‑care/telemedicine platforms (broad scope; good for ongoing care) One Medical — ongoing primary care with virtual visits; good continuity and coordination with labs and imaging. PlushCare — primary care and chronic disease management via telehealth; often prescribes diabetes and weight‑loss medications after evaluation. Teladoc / MDLive — large telehealth networks that can connect you to a clinician for diabetes/weight management prescriptions when appropriate. Primary care or endocrinology telemedicine within your health system — the best option for complex diabetes or medication changes. Specialized weight‑loss/GLP‑1 telehealth companies (focus on metabolic/weight programs) Calibrate — structured metabolic program focused on long‑term weight and metabolic health; has offered GLP‑1s as part of its program. Done (getdone.com) — DTC telehealth company focused on GLP‑1 therapy and weight management (evaluations, prescriptions, follow‑up). Hims & Hers (telehealth branch) — consumer telehealth that has added GLP‑1/tirzepatide options in many markets. Ro (Roman) — offers telehealth services that have included weight‑loss medication programs. Telehealth + price‑shopping / prescription services GoodRx Care (HeyDoctor/GoodRx) — inexpensive telehealth visits and can send prescriptions to pharmacies; useful for price comparisons and coupons. Lemonaid Health — telemedicine and medication delivery for a range of conditions; availability varies by state. How the online process typically works You complete an intake (medical history, medications, recent labs), have a tele‑visit with a licensed clinician (MD, DO or NP), and if appropriate they prescribe and arrange follow‑up. Many services require or order baseline labs (A1c, kidney function, pregnancy test if applicable). State licensing matters — the clinician must be licensed in your state, so not all services cover all states. Practical next steps Decide your primary goal: blood‑sugar control vs. weight loss — that influences drug choice. Contact your PCP or endocrinologist if possible (best continuity). If you need a telehealth visit, pick a reputable service above and confirm they prescribe GLP‑1s/tirzepatide in your state. Ask about prior authorization, cost-sharing, coupons (GoodRx), and alternatives if a particular brand is out of stock. Be honest about pregnancy plans, family history of thyroid cancer, pancreatitis, and current meds. If you want, tell me: Is your goal diabetes control or weight loss? Are you looking for an in‑person clinic or only online/telehealth? Your state (to suggest services that operate there)? I can then suggest 2–3 specific services to try and what to expect in the intake questions.

Mentioned in position 7 of 21

Short answer first: If you can’t get Ozempic (semaglutide), there are several medically reasonable alternatives — other GLP‑1 drugs, the newer dual GIP/GLP‑1 drug tirzepatide, and non‑GLP‑1 diabetes medicines — and many telehealth/online primary‑care and weight‑loss clinics will evaluate and (if appropriate) prescribe them. Which alternatives to consider (briefly why) Tirzepatide (brand names: Mounjaro for diabetes; Zepbound is the tirzepatide brand for chronic weight management) — often produces greater blood‑sugar lowering and weight loss than semaglutide in trials. Other GLP‑1 agonists: Wegovy (semaglutide 2.4 mg) — semaglutide formulation approved specifically for weight loss. Rybelsus (oral semaglutide) — oral version of semaglutide if you can’t or don’t want injections. Victoza (liraglutide) — established GLP‑1 for diabetes; Saxenda is liraglutide for weight loss. Trulicity (dulaglutide) — once‑weekly GLP‑1 for type 2 diabetes. Bydureon/Byetta (exenatide) — longer‑ and shorter‑acting exenatide options. Non‑GLP‑1 diabetes medicines (if GLP‑1s aren’t suitable): Metformin (first‑line for type 2 diabetes). SGLT2 inhibitors (Jardiance/empagliflozin, Farxiga/dapagliflozin) — help blood sugar and have heart/kidney benefits. DPP‑4 inhibitors (Januvia/sitagliptin) or insulin — depending on disease stage. Who prescribes them online Large telehealth/online primary‑care platforms: PlushCare, Carbon Health, Teladoc/Amwell (including Doctor On Demand), and GoodRx Care often provide evaluations and can prescribe diabetes and weight‑loss medications when appropriate. Direct‑to‑consumer telemedicine/weight‑loss services that commonly prescribe GLP‑1 or tirzepatide: Ro (Roman), Hims & Hers, Lemonaid Health, Calibrate, and some specialized weight‑management clinics that operate virtually. Local telemedicine through your primary‑care practice or endocrinology clinic: many PCPs and endocrinologists now offer virtual visits and can manage these meds. Note: different services have different formularies and rules — some will prescribe GLP‑1s/tirzepatide for obesity or diabetes, some will not; prior authorization or in‑person/lab requirements may apply. Safety and practical notes Any GLP‑1 or tirzepatide prescription should follow a clinician evaluation (medical history, possible labs, pregnancy status, pancreatitis risk, personal/family medullary thyroid cancer or MEN2 history, etc.). Some drugs are approved for diabetes vs. for weight management (e.g., Ozempic/Mounjaro are diabetes brands; Wegovy/Zepbound are obesity brands); insurers often require specific diagnoses or prior authorization. Avoid buying injectables from unverified sources or online marketplaces. Use licensed telemedicine + a reputable pharmacy. If you want, tell me: Are you using Ozempic for type 2 diabetes or for weight loss? Do you prefer in‑person care, or want telehealth only? I can then suggest specific services more likely to meet your situation and list what you’ll need for the first visit.

Mentioned in position 7 of 21